Biological

Therapeutic Autologous Dendritic Cells clinical trials

studies test it: 12
open now: 0
in phase 3: 0
first study started: 1996

How studies write it

Studies that test it under each name

Name

therapeutic autologous dendritic cells: 12

Studies by the year they started

12 studies that test it; most in 2000 (3)

Studies that test Therapeutic Autologous Dendritic Cells, by start year
Year	Studies
1996	1
2000	3
2003	1
2005	3
2006	1
2008	1
2009	1
2013	1

By phase

A phase 1/2 study counts in both.

Phase 1: 8
Phase 2: 5

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Renal Cell: 2
Glioma: 2
Melanoma: 2
Prostatic Neoplasms: 2
Colorectal Neoplasms: 1
Carcinoma in Situ: 1
Sarcoma: 1
Leukemia: 1

Who runs them

Industry 1 · Other 11

Jonsson Comprehensive Cancer Center (3) · Duke University (2) · Michael Morse, MD (1) · Abramson Cancer Center at Penn Medicine (1) · Lisata Therapeutics, Inc. (1) · Hoag Memorial Hospital Presbyterian (1) · National Cancer Institute (NCI) (1) · Institut Paoli-Calmettes (1)

Often tested with

Tested in the same studies.

Sargramostim (1) · Autologous Tumor Cell Vaccine (1) · Indinavir (1) · Allogeneic Tumor Cell Vaccine (1)

Studies

Open first, then newest update. How each study uses Therapeutic Autologous Dendritic Cells is read from its arms, and is right about nine times in ten.

Testing it · 12

Given in every arm · 10 — Therapeutic Autologous Dendritic Cells is usual care beside what is tested